Geopolitics Alpha

Is Lower Revenue Guidance Altering The Investment Case For Progyny Stock (PGNY)?

Published . Updated .

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHAIs Lower Revenue Guidance AlteringThe Investment Case For ProgynyStock (PGNY)?PGNYGEOPOLITICS ALPHA

This report does not map to a usual set of affected companies.

Directly affected

  • PGNY Progyny+21.7% 7d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Progyny belongs to, so it often moves with news about it.

  • DVA DaVita-1.3% 30d

    DaVita is a peer of Progyny in misc health and allied services; rivals often move on the same news.

  • SHC Sotera Health+1.9% 8d

    Sotera Health is a peer of Progyny in misc health and allied services; rivals often move on the same news.

  • FMS Fresenius Medical Care AG-7.5% 11d

    Fresenius Medical Care AG is a peer of Progyny in misc health and allied services; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
PGNY-3.63%-4.57%base+0.74%-0.50%+2.88%+17.87%
XLV-3.03%-2.77%base-0.14%-0.48%+2.59%+0.17%
DVA-1.98%-1.90%base-1.07%-2.86%+2.69%+3.89%
SHC+1.43%+2.87%base-2.21%-11.69%-9.65%-12.47%
FMS+1.25%+0.67%base+0.62%-3.34%+3.16%+5.27%

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Is Lower Revenue Guidance Altering The Investment Case For Progyny Stock (PGNY)? Yahoo Finance

Source: Yahoo Finance

This story

CompanyWhenMoveStatus
DVAthat day-1.07%final price
DVAthe next day-2.86%final price
DVAtwo days later+2.69%final price
DVAthree days later+3.89%final price
DVAthree days earlier-1.90%final price
DVAfive days earlier-1.98%final price
FMSthat day+0.62%final price
FMSthe next day-3.34%final price
FMStwo days later+3.16%final price
FMSthree days later+5.27%final price
FMSthree days earlier+0.67%final price
FMSfive days earlier+1.25%final price
PGNYthat day+0.74%final price
PGNYthe next day-0.50%final price
PGNYtwo days later+2.88%final price
PGNYthree days later+17.87%final price
PGNYthree days earlier-4.57%final price
PGNYfive days earlier-3.63%final price
SHCthat day-2.21%final price
SHCthe next day-11.69%final price
SHCtwo days later-9.65%final price
SHCthree days later-12.47%final price
SHCthree days earlier+2.87%final price
SHCfive days earlier+1.43%final price
XLVthat day-0.14%final price
XLVthe next day-0.48%final price
XLVtwo days later+2.59%final price
XLVthree days later+0.17%final price
XLVthree days earlier-2.77%final price
XLVfive days earlier-3.03%final price

This story

12 out of 100

“Is Lower Revenue Guidance Altering The Investment Case For Progyny Stock (PGNY)?” scores 12 out of 100. The score uses 1 sources.